Seeking Alpha / - 45 minutes from now
Municipality Finance will redeem early notes issued under its MTN programme
Municipality Finance PlcStock exchange release 30 October 2025 at 2:00 pm (EET)
By Super Admin
Seeking Alpha / - 45 minutes from now
Kuntarahoitus Oyj eräännyttää ennenaikaisesti osana joukkovelkakirjaohjelmaa liikkeeseenlasketun joukkovelkakirjalainan
Kuntarahoitus OyjPörssitiedote30.10.2025 klo 14.00
Seeking Alpha / - 45 minutes from now
Harvia will publish its Interim report for January–September 2025 on Thursday, 6 November 2025 at around 9:00 a.m. EET
Harvia Plc press release 30 October 2025 at 2.00 p.m. EET
Seeking Alpha / - 45 minutes from now
Harvia julkaisee tammi–syyskuun 2025 osavuosikatsauksen torstaina 6.11.2025 noin klo 9.00
Harvia Oyj:n lehdistötiedote 30.10.2025 klo 14.00
Seeking Alpha / - 45 minutes from now
Kojamo plc’s Interim Report 1 January–30 September 2025
Kojamo plc Stock Exchange Release, 30 October 2025 at 2.00 p.m. EET
Seeking Alpha / - 45 minutes from now
Next-Generation of Optical Ethernet PHY Transceivers Deliver Precision Time Protocol and MACsec Encryption for Long-Reach Networking
Microchip’s new transceivers are offered at speeds up to 25 Gbps to process more data Microchip’s new transceivers are offered at speeds up to 25 Gbps to process more data
Seeking Alpha / - 45 minutes from now
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on Thursday, November 6, 2025, after the close of U.S. ma...
Seeking Alpha / - 45 minutes from now
Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ObesityWeek® 2025, taking place November 4-7, 2025 in Atlanta, Georgia.
Seeking Alpha / - 45 minutes from now
Lifetime Brands Announces Third Quarter 2025 Financial Results Release Date and Conference Call
GARDEN CITY, N.Y., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifetime Brands, Inc. (NasdaqGS: LCUT) (the “Company”), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its third quarter 2025 financial results before market open on...
Seeking Alpha / - 45 minutes from now
ORYZON to Participate in Upcoming Events in November
MADRID, Spain and CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:
Seeking Alpha / - 45 minutes from now
SONORO GOLD COMPLETES FINAL CONCESSION PAYMENT AND PROVIDES CORPORATE UPDATE
VANCOUVER, Canada, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce the Company has made the final concession payment on its flagship Cerro Caliche gold project in Sonora, Mexico. In March 2018, the Compan...
Seeking Alpha / - 45 minutes from now
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its third quarter financial results after the...
Seeking Alpha / - 45 minutes from now
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
Conference Call and Webcast Scheduled for Thursday, November 6th, 2025, at 10:00 AM ET Conference Call and Webcast Scheduled for Thursday, November 6th, 2025, at 10:00 AM ET
Seeking Alpha / - 45 minutes from now
Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
Seeking Alpha / - 45 minutes from now
XWELL Expands Priority Pass Partnership to Bring Wellness Worldwide
Priority Pass members can now enjoy XWELL’s exclusive wellness experiences at select international airport spas Priority Pass members can now enjoy XWELL’s exclusive wellness experiences at select international airport spas